Skyrizi 150 mg/ml Enjeksiyonluk Çözelti İçeren Kullanima Hazir Enjektör
Abbvie Tibbi İlaçlar San. ve Tic. Ltd. Şti.
Skyrizi 150 mg/ml Enjeksiyonluk Çözelti İçeren Kullanima Hazir Enjektör Nedir ve Ne İçin Kullanılır?
1 \000. \0008 \000/ \000/ \000$ \0001 \0000 \000$ \000 \0007 \000$ \000/ \000? \0000 \000$ \0007 \000, \000 \0006 \000. \000< \0005 \000, \000= \000, \000 \000 \000 \000 \000 \000P \000J \000 \000P \000/ \000 \000H \000Q \000M \000H \000N \000V \000L \000\\ \000R \000Q \000O \000X \000N \000 \000o \000| \000] \000H \000O \000W \000L \000 \000L \000o \000H \000U \000H \000Q \000 \000N \000X \000O \000O \000D \000Q \000? \000P \000D \000 \000K \000D \000] \000? \000U \000 \000H \000Q \000M \000H \000N \000W \000| \000U \000 \000 Steril \000' \000H \000U \000L \000 \000D \000O \000W \000? \000Q \000D \000 \000H \000Q \000M \000H \000N \000V \000L \000\\ \000R \000Q \000 \000\\ \000R \000O \000X \000\\ \000O \000D \000 \000X \000\\ \000J \000X \000O \000D \000Q \000? \000U \000 \000
? \000+ \000H \000U \000 \000E \000L \000U \000 \000N \000X \000O \000O \000D \000Q \000? \000P \000D \000 \000K \000D \000] \000? \000U \000 \000H \000Q \000M \000H \000N \000W \000| \000U \000 \000 \000 \000 \000P \000/ \000 \000o \000| \000] \000H \000O \000W \000L \000G \000H \000 \000 \000 \000 \000 \000P \000J \000 \000U \000L \000V \000D \000Q \000N \000L \000] \000X \000P \000D \000E \000 \000L \000o \000H \000U \000L \000U \000 \000 Etkin madde: ? \000< \000D \000U \000G \000? \000P \000F \000? \000 \000P \000D \000G \000G \000H \000O \000H \000U \000 \000 Sodyum asetat trihidrat \(E262\, asetik asit \(E260\, trehaloz dihidrat, polisorbat 20, enjeksiyonluk su.
\000% \000X \000 \000L \000O \000D \000o \000 \000H \000N \000 \000L \000] \000O \000H \000P \000H \000\\ \000H \000 \000W \000D \000E \000L \000G \000L \000U \000 \000 \000% \000X \000 \000? \000o \000J \000H \000Q \000 \000\\ \000H \000Q \000L \000 \000J \000? \000Y \000H \000Q \000O \000L \000O \000L \000N \000 \000E \000L \000O \000J \000L \000V \000L \000Q \000L \000Q \000 \000K \000? \000] \000O \000? \000 \000R \000O \000D \000U \000D \000N \000 \000E \000H \000O \000L \000U \000O \000H \000Q \000P \000H \000V \000L \000Q \000L \000 \000V \000D \000? \000O \000D \000\\ \000D \000F \000D \000N \000W \000? \000U \000 \000 \0000 \000H \000\\ \000G \000D \000Q \000D \000 \000J \000H \000O \000H \000Q \000 \000K \000H \000U \000K \000D \000Q \000J \000L \000 \000E \000L \000U \000 \000\\ \000D \000Q \000 \000H \000W \000N \000L \000\\ \000L \000 \000U \000D \000S \000R \000U \000O \000D \000\\ \000D \000U \000D \000N \000 \000\\ \000D \000U \000G \000? \000P \000F \000? \000 \000R \000O \000D \000E \000L \000O \000L \000U \000V \000L \000Q \000L \000] \000 \000 \000< \000D \000Q \000 \000H \000W \000N \000L \000O \000H \000U \000L \000Q \000 \000Q \000D \000V \000? \000O \000 \000U \000D \000S \000R \000U \000O \000D \000Q \000D \000F \000D \000? \000? \000Q \000? \000 \000| \000? \000U \000H \000Q \000P \000H \000N \000 \000L \000o \000L \000Q \000 \000 \000 \000 \000% \000| \000O \000? \000P \000? \000Q \000 \000V \000R \000Q \000X \000Q \000D \000 \000E \000D \000N \000D \000E \000L \000O \000L \000U \000V \000L \000Q \000L \000] \000
\000% \000X \000 \000. \000X \000O \000O \000D \000Q \000P \000D \000 \0007 \000D \000O \000L \000P \000D \000W \000? \000Q \000G \000D : \000 \000 \000 \0006 \000. \000< \0005 \000, \000= \000, \000 \000Q \000H \000G \000L \000U \000 \000Y \000H \000 \000Q \000H \000 \000L \000o \000L \000Q \000 \000N \000X \000O \000O \000D \000Q \000? \000O \000? \000U \000" \000 2. SKYRIZI?yi kullanmadan ?nce dikkat edilmesi gerekenler \000 \000 \000 \0006 \000. \000< \0005 \000, \000= \000, \000 \000Q \000D \000V \000? \000O \000 \000N \000X \000O \000O \000D \000Q \000? \000O \000? \000U \000" \000 \000 \000 \000 \0002 \000O \000D \000V \000? \000 \000\\ \000D \000Q \000 \000H \000W \000N \000L \000O \000H \000U \000 \000Q \000H \000O \000H \000U \000G \000L \000U \000" \000 \000 \000 \000 \0006 \000. \000< \0005 \000, \000= \000, \000? \000Q \000L \000Q \000 \000V \000D \000N \000O \000D \000Q \000P \000D \000V \000? \000 \000% \000D \000? \000O \000? \000N \000O \000D \000U \000? \000 \000\\ \000H \000U \000 \000D \000O \000P \000D \000N \000W \000D \000G \000? \000U \000 \000
\000 \000 \000 \0006 \000. \000< \0005 \000, \000= \000, \000 \000Q \000H \000G \000L \000U \000 \000Y \000H \000 \000Q \000H \000 \000L \000o \000L \000Q \000 \000N \000X \000O \000O \000D \000Q \000? \000O \000? \000U \000" \000 \000W \000H \000N \000Q \000R \000O \000R \000M \000L \000V \000L \000 \000D \000G \000? \000 \000Y \000H \000U \000L \000O \000H \000Q \000 \000E \000L \000U \000 \000W \000H \000N \000Q \000L \000N \000 \000N \000X \000O \000O \000D \000Q \000? \000O \000D \000U \000D \000N \000 \000o \000L \000Q \000 \000K \000D \000P \000V \000W \000H \000U \000L \000 \000K \000? \000F \000U \000H \000O \000H \000U \000L \000Q \000G \000H \000 \000? \000U \000H \000W \000L \000O \000H \000Q \000 \000 \000L \000Q \000W \000H \000U \000O \000| \000N \000L \000Q \000 \000 \000, \000/ \000\f \000 \000 \000 \000 \000S \000U \000R \000W \000H
Eşdeğer İlaçlar (Aynı Etken Madde)
Sıkça Sorulan Sorular
Skyrizi 150 mg/ml Enjeksiyonluk Çözelti İçeren Kullanima Hazir Enjektör ne için kullanılır?
Önemli Uyarı: Bu sayfadaki bilgiler yalnızca bilgilendirme amaçlıdır ve tıbbi tavsiye yerine geçmez. İlaç kullanımı konusunda mutlaka doktorunuza veya eczacınıza danışınız. Kendi başınıza ilaç başlatmayın, değiştirmeyin veya bırakmayın. Kaynak: T.C. Sağlık Bakanlığı TİTCK.